Under the terms of the agreement, AstraZeneca will leverage Immunai’s platform and machine learning capabilities to inform certain oncology clinical trials.
Discover the revolution in CLL treatment: Dr. Evelyn Shabad and Carol Gilad share insights on follow-up, short-term treatment, and surprising results without major side effects.
Researchers at Tel Aviv University found that aneuploid cancer cells are more sensitive to certain anti-cancer drugs, revealing potential targets for new treatments.
Pioneering Kidney Cancer Study Seeks to Improve Treatment Outcomes through Precision Medicine
TECH TALK | No one loves needing to ask for a helping hand, but when potentially life-saving technology is at stake, some extra measures must be taken.
“We discovered that certain metals binding within the matrix can alter its structure, forming complexes that serve as the fundamental units of memory," researchers wrote.
A new technology developed at Bar-Ilan University will help oncologists and other medical professionals to determine the best way to treat patients.
All of our fighters need our help, but let’s not forget those among us who are fighting day in and day out, in peacetime and now even in war, against a bitter enemy that can strike anyone, anytime.
The developed technology was recently licensed to a biomedical company (Vaxil Biotherapeutics) for further clinical development.
Groundbreaking study at Tel Aviv University: Existing drugs may hinder the development of bone metastasis in breast cancer patients
JPOST Digital Library
